CompaniesSigma-Aldrich

Sigma-Aldrich

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

365

By Phase

PHASE1/PHASE2: 1PHASE1: 1

By Status

RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04540107
NCT05599048
Hover over trial bars to see details

Recent Trials

NCT05599048Collaborator
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
65 participants
Started: Dec 15, 2022 · Completed: Jan 31, 2026
NCT04540107Collaborator
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
PHASE1Recruiting
300 participants
Started: Jan 11, 2017 · Completed: Jan 31, 2027